Interactions between inotropic drugs.
Ducart
A
A
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; D004077:Digoxin / Q000494:pharmacology; D018491:Dopamine Agonists / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D014284:Triiodothyronine / Q000494:pharmacology; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy
D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D018491:Dopamine Agonists; D010726:Phosphodiesterase Inhibitors; D014284:Triiodothyronine; D004077:Digoxin; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; D002118:Calcium